Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

Nike CEO Elliott Hill told Fortune magazine Fever star Caitlin Clark visited headquarters this month to continue development ...

On episode two of Bravo Bravo F-Ing Bravo, Kate Chastain welcomes Married To Medicine's Dr. Heavenly Kimes, The Real Housewives of Salt Lake City's Heather Gay and Virtual Reali-Tea podcast host ...

Kate Middleton ended 2024 on a high note by announcing that her cancer is in remission. Since then, the Princess of Wales, 43, has accompanied her husband, Prince William, on multiple official ...

Fraser Murray, PhD, CEO, Pheno Therapeutics. Image Credit: Pheno Therapeutics A selective GPR17 (G protein-coupled receptor 17) antagonist, PTD802 is a novel small molecule therapeutic designed to ...

Kate Middleton returned to the public eye today, stepping out for her first engagement of the new year. The Princess of Wales chose a very important location to her: Royal Marsden Hospital, the ...

William and Kate's three children are heirs to the throne. Prince William and Kate, the Princess of Wales, may hold the titles of Britain's future king and queen, but the couple's most important ...

The Princess of Wales released a statement saying she is in remission from cancer and focused on recovery, having earlier visited staff and patients at The Royal Marsden Hospital where she ...

EMERYVILLE, Calif., Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing ...

EMERYVILLE, Calif., Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...

New Year, New Me isn’t for everyone – and it appears some commentators have failed to learn from the mistakes of 2024. The Princess of Wales is already the subject of fervent speculation from ...